D.Western Therapeutics Institute Inc (4576) Stock Price & News

Why is 4576 down 6.78%?

Dive Deeper

4576:TYO

D.Western Therapeutics Institute Inc

¥55.00

-6.78%

(-4.00) 1D

Nov 4, 3:30:00 PM GMT+9 · JPY

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 4576...

Open

¥58

High

¥58

Low

¥54

Mkt. cap

3.23B

Avg. vol.

327.69K

Volume

640.40K

52-wk high

¥111

52-wk low

¥54

EPS

-¥12

Shares outstanding

26.28M

No. of employees

Open

¥58

High

¥58

Low

¥54

Mkt. cap

3.23B

Avg. vol.

327.69K

Volume

640.40K

52-wk high

¥111

52-wk low

¥54

EPS

-¥12

Shares outstanding

26.28M

No. of employees

Related stocks

OncoTherapy Science, Inc.

¥17.00

0.00%

4583

Chiome Bioscience Inc

News stories

From web sources and news partners

FinancialContent

30 minutes ago

U.S. Physical Therapy (NYSE:USPH) reports strong Q3 2026

shattered.io

37 minutes ago

S&P Earnings Jump 30.2% as Big Tech Cash Flow Sinks [2026]

Quantisnow

56 minutes ago

/C O R R E C T I O N - SVRN, Inc./

MarketWatch

1 hour ago

Dow scores its best day in 18 months in a broad relief rally after Democrats sweep to power in Congress

About D.Western Therapeutics Institute Inc

CEO-

Employees19

FoundedFeb 26, 1999

Headquarters-

SectorBiotechnology

Industry-

Websitedwti.co.jp

All values in JPY	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	123.86M	89.90M	15.11M	17.89M
Cost of goods sold	12.59M	8.94M	-	-
Cost of revenue	12.59M	8.94M	-	-
Research and development expenses	217.16M	133.58M	117.54M	99.46M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	63.53M	87.94M	64.83M	64.17M
Operating expense	280.88M	223.40M	182.37M	163.63M
Total operating expenses	293.47M	232.34M	182.37M	163.63M
Operating income	-169.61M	-142.43M	-167.25M	-145.75M
Other non operating income	-7.48M	-1.81M	-1.20M	-5.80M
EBT including unusual items	-175.45M	-139.48M	-170.40M	-152.60M
EBT excluding unusual items	-175.45M	-139.48M	-170.40M	-152.60M
Income tax expense	399.00K	-196.00K	398.00K	-398.00K
Effective tax rate	-0.23%	0.14%	-0.23%	0.26%
Other operating expenses	-	-	-	-
Net income	-175.85M	-139.28M	-170.80M	-152.20M
Net profit margin	-141.98%	-154.93%	-1,130.12%	-850.93%
Earnings per share	-	-	-	-
Interest and investment income	787.00K	440.00K	1.27M	734.00K
Interest expense	-2.09M	-1.92M	-3.20M	-2.80M
Net interest expenses	-1.30M	-1.48M	-1.93M	-2.07M
Depreciation and amortization charges	-	1.00M	-	-
EBITDA	-157.28M	-130.68M	-155.37M	-144.75M
Gain or loss from assets sale	-	-	-	-

Finance

Ask anything